AIDX Healwell AI Inc.
Healwell AI Inc. operates as a healthcare technology company in Canada, Australia, and New Zealand. The company operates in two segments, AI and Data Sciences, and Healthcare Software. It focuses on developing and commercializing clinical decision support systems to help healthcare providers detect rare and chronic diseases. The company provides healthcare artificial intelligence engines, electronic health record platform, healthcare data management and interoperability software, and early/late phase contract clinical research services. It also offers rare and chronic disease screening, real world evidence clinical study generation, advanced clinical decision support, and physical ASI co-pilot tools. It serves public sector organizations, healthcare providers, insurers, and life science companies. The company was formerly known as MCI Onehealth Technologies Inc. and changed its name to Healwell AI Inc. in September 2023. Healwell AI Inc. was incorporated in 2012 and is headquartered in Toronto, Canada.…
Industry Peers
Medical Care FacilitiesKey Statistics
About Healwell AI (TSE: AIDX)
›
Healwell AI (TSE: AIDX) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 570 employees.
The shares were at 0.5100 CAD on 19 November 2026, down 65.5% over 52 weeks. Its 52-week range is 0.4900 CAD to 1.505 CAD: the price is 66.1% below the high and 4.1% above the low.
Its market capitalisation is 170.52M CAD.
Healwell AI reports return on equity of -38.0%, an operating margin of -16.6% and revenue up 7.3% year over year.
Its debt exceeds its cash by 53.70M CAD, a debt-to-equity ratio of 0.69. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 10 analysts cover the stock, with an average rating of Buy; their mean price target of 1.520 CAD is 198.0% above the current price. The next earnings report is expected on 18 March 2027.